Tirzepatide 60mg

High-Potency Dual GIP & GLP-1 Peptide for Metabolic Research

Tirzepatide 60mg is a high-strength, research-grade peptide studied for its effects on metabolic health, glucose regulation, appetite control, and body weight management. As a dual GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor agonist, tirzepatide activates two complementary hormone pathways involved in insulin secretion, satiety, and energy balance. This dual mechanism has demonstrated significant improvements in glycemic control and weight reduction in clinical studies.

The 60mg formulation provides a higher total peptide content, making it suitable for extended laboratory research protocols while maintaining high purity and stability.

Product Highlights

• Peptide: Tirzepatide
• Strength: 60mg per vial
• Category: Dual GIP & GLP-1 Receptor Agonist
• Form: Lyophilized (freeze-dried) peptide powder
• Administration: Reconstituted for subcutaneous injection in research settings
• Quality: High-purity research-grade peptide

What Is Tirzepatide Made Of?

Tirzepatide is a synthetic 39-amino acid peptide engineered to activate both GIP and GLP-1 receptors. It incorporates a C20 fatty diacid side chain that promotes albumin binding, extending its half-life and supporting once-weekly dosing in approved therapeutic formulations.

What Is Tirzepatide Studied For?

Tirzepatide has been extensively studied for its potential role in:

• Supporting healthy weight management
• Improving blood glucose control
• Enhancing insulin secretion when glucose levels are elevated
• Reducing appetite and food cravings
• Increasing feelings of fullness (satiety)
• Slowing gastric emptying
• Improving insulin sensitivity
• Supporting long-term metabolic health
• Investigating obesity and type 2 diabetes management

Clinical studies have shown substantial reductions in body weight along with significant improvements in glycemic control in appropriate patient populations.

Potential Benefits

• Supports metabolic and obesity research
• May promote healthy body weight
• Helps regulate blood glucose metabolism
• May reduce appetite and caloric intake
• Supports prolonged satiety
• High-purity peptide for laboratory research
• Extended-duration peptide designed for once-weekly administration in approved medical use

How It Works

Tirzepatide simultaneously activates GIP and GLP-1 receptors.

Together, these pathways may help:

• Stimulate glucose-dependent insulin secretion
• Reduce glucagon secretion
• Slow gastric emptying
• Suppress appetite
• Increase satiety after meals
• Improve glucose utilization and insulin sensitivity
• Promote greater fat mass reduction while preserving lean body mass

Its dual-receptor mechanism is believed to provide enhanced metabolic benefits compared with therapies targeting only the GLP–1 pathway.

Storage

• Store the unopened lyophilized vial in a cool, dry place.
• After reconstitution, refrigerate according to laboratory protocol.
• Protect from excessive heat, moisture, and direct light.
• Do not use if the solution becomes cloudy or contains particulate matter.

Important Information

Tirzepatide is available as an FDA-approved prescription medication for specific medical indications when prescribed by a licensed healthcare professional. Research-grade Tirzepatide formulations are intended for laboratory research purposes only

Verifiable Batches • 99%+ Purity Guaranteed • Ships Quickly